It has been previously reported that different TCF4 isoforms generated by alternative splicing events activated different downstream target genes in hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC)40–42. The gene discussed is TCF4; the disease is hepatocellular carcinoma.